PROGRAM CHAIRS
Cecelia Koetting, OD, FAAO, DipABO
Assistant Professor
University of Colorado School of Medicine
Denver, Colorado
Walter Whitley, OD, MBA, FAAO
Director of Professional Relations and Education
Virginia Eye Consultants
Regional Medical Director – Mid-Atlantic
EyeCare Partners, LLC
Norfolk, Virginia
PROGRAM OVERVIEW
This educational activity is designed to enhance medical professionals’ expertise in managing Demodex blepharitis by improving their ability to apply best practices for its early detection and accurate differentiation from other ocular conditions to ensure timely diagnosis. It will enable participants to assess the latest clinical evidence on novel therapeutics and their impact on patient outcomes, and equip them to integrate emerging agents into individualized management strategies.
TARGET AUDIENCE
This activity is intended to meet the educational needs of optometrists, ophthalmologists, and optometry technicians involved in the diagnosis and management of patients with Demodex blepharitis.
LEARNING OBJECTIVES
Upon completion of this activity, attendees will have improved ability to:
- Explain best practices for early detection and differentiation of Demodex blepharitis from other ocular conditions to ensure timely and accurate diagnosis.
- Evaluate the latest clinical data on novel therapeutics for Demodex blepharitis and their role in improving patient outcomes.
- Implement new and emerging agents into individualized treatment paradigms for patients with Demodex blepharitis based on the most up-to-date clinical evidence.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.0 ANCC contact hour.
COPE CREDIT DESIGNATION
Med Learning Group designates this asynchronous activity for a maximum of 1.0 COPE credit hour.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Cecelia Koetting, OD | Discloses that she has had consulting fees with Théa Pharma, Aldeyra Therapeutics, Bruder Healthcare, Allergan, AbbVie, Visus Therapeutics, Orasis Pharmaceuticals, Tarsus Pharmaceuticals, Alcon, Glaukos, Dompé, SightSciences, Bausch & Lomb, Twenty/Twenty Therapeutics, Myze, Azura Ophthalmics, BlinkJoy, Versea Diagnostics, and Topcon Healthcare. She participated in speakers bureaus for Alcon, AbbVie, Bausch & Lomb, Tarsus Pharmaceuticals, Harrow, Orasis Pharmaceuticals, and Dompé. Lastly, she participated in research for Orasis Pharmaceuticals, Bausch and Lomb, Tarsus, and Kala. |
| Walter Whitley, OD | Discloses that he has had consulting fees with Alcon, Aldeyra Therapeutics, AbbVie, Apellis Pharmaceuticals, CSI Dry Eye Inc., Epion, Glaukos, Harrow, I2-Vision, Inc., Iveric, Mediprint Pharma, Nordic Pharma, OD Immersion, and Regener-Eyes. Dr. Whitley has participated as a speaker for Alcon, Apellis Pharmaceuticals, Bausch and Lomb, Dompe, Lenz, and Science Based Health. He was on an advisory board for Alcon, Bausch and Lomb, Bruder Healthcare, Dompe, and Science Based Health. Lastly, he was a contributing editor for Review of Optometry. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Lauren Scott, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Shannon Mutch, BS, BSN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Marissa Mays-Verman, Program Director for Med Learning Group, has nothing to disclose.
- Alexis Klinger, Associate Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: November 11, 2025
EXPIRATION DATE: November 11, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
